期刊文献+

黑热病合并HIV感染3例误诊分析 被引量:4

Analysis of Misdiagnosis about three cases with Leishmaniasis and HIV Co-infection
下载PDF
导出
摘要 目的探讨黑热病合并HIV感染误诊的原因及防范策略。方法回顾性分析3例黑热病合并HIV感染患者的临床资料。结果该3例主要表现为长期反复出现不规则发热、全血细胞减少、肝脾淋巴结肿大和皮肤损害等症状,骨髓或淋巴结穿刺物涂片中均检出利什曼原虫无鞭毛体,血清免疫学检查为强阳性。结论黑热病合并HIV感染的临床表现虽无特异性,但实验室检查灵敏度和特异性较高,提高非疫源性地区医务人员的诊断意识和能力、及时完善实验室的各项检查,可避免或减少其误诊。 Objective To analyze the causes and discuss the preventive measures of misdiagnosis of three cases with Leishmaniasis and HIV Co-infection. Methods Retrospectively analyze the correlative clinical information and laboratory datas of the three cases. Results The long-term irregular fever,pancytopenia, hepatosplenomegaly and skin lesion are the common typical clinical symptoms. Leishmanias which have no atrichosis were found in the bone marrow and pathological lymph nodes of the three patients, and the seroimmunity tests were all strong- ly positive. Conclusion Although the clinical symptoms of leishmaniasis and HIV Co-infection are not specif- ic, the sensitivity and specificity of laboratory tests were high. To improve the Medical Staff's diagnosis ability and perfect the correlative laboratory tset is the key to reduce the misdiagnosis.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2011年第7期567-568,共2页 The Chinese Journal of Dermatovenereology
关键词 黑热病 HIV感染 非疫源性地区 误诊 Leishmaniasis HIV infection Non-epidemic focus Misdiagnosis
  • 相关文献

参考文献5

二级参考文献23

  • 1Delgado J, Macias J, Pineda JA, et al. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. Am J Trop Med
  • 2Ramos-Santos C, Hernandez-Montes O, Sanchez-Tejeda G, et al.Visceral leishmaniasis caused by Leishmania (L.) mexicana in a Mexican patient with human immunodeficiency virus infection.Mem Inst Oswaldo Cruz,2000,95(5): 733-737.
  • 3Desjeux P. Leishmania and HIV in Gridlock. Document WHO/CTD/LEISH/98.23 Geneva: WHO, 1998.
  • 4Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans Roy Soc Trop Med Hyg, 2001,95(3): 239-243.
  • 5WHO: Manual on visceral leishmaniasis control. Document WHO/LEISH/96.40. Geneva: WHO, 1996.
  • 6Lynos S, Veeken H, Long J. Visceral leishmaniasia/HIV in Tigray Ethiopia. Trop Med Int Hlth,2003, 8(8): 733-739.
  • 7Mereno J, Canavate C, Chamizo C, et al. HIV-Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy. Trans Roy Soc Trop Med Hyg,2000,94(3): 328-332.
  • 8Berhe N, Hailu A, Wolday D, et al. Ethiopian visceral leishmaniasia patients co-infected with human immunodeficiency virus. Trans Roy Soc Trop Med Hyg, 1995, 89(2): 205-207.
  • 9Fischer C, Engel K, Bommer W. Treatment of VL/HIV coinfected patients with oral miltefosine. In: Abstract Book of Second World Congress on Leishmaniasis, Crete-Greece. 2001,24.
  • 10Gradoni L, Gramiccia M. Leishmania infantum tropism: strain genotype or host immune status? Parasitol Today, 1994, 10 (7):264-267.

共引文献11

同被引文献35

引证文献4

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部